Literature DB >> 2554785

Recombinant human interferon alpha-2b enhances the radiosensitivity of small cell lung cancer in vitro.

D Kardamakis1, N E Gillies, R L Souhami, P C Bewerley.   

Abstract

We have studied the effects of human recombinant interferon alpha on the radiobiological response and the cell cycle distribution of human small cell lung cancer cell lines. In two small cell lung cancer cell lines tested so far, pretreatment with interferon alpha was found to increase the radiation sensitivity without altering the distribution of cells in the cell cycle.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2554785

Source DB:  PubMed          Journal:  Anticancer Res        ISSN： 0250-7005            Impact factor:   2.480


  3 in total

1.  Escalating doses of interferon alpha-2A with cisplatin and concomitant radiotherapy: a phase I study.

Authors:  E E Vokes; D J Haraf; P C Hoffman
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

2.  A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.

Authors:  E E Vokes; D J Haraf; L C Drinkard; P C Hoffman; M K Ferguson; N J Vogelzang; S Watson; N J Lane; H M Golomb
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

3.  Bridging Radiotherapy to Immunotherapy: The IFN-JAK-STAT Axis.

Authors:  Lewis Zhichang Shi; James A Bonner
Journal:  Int J Mol Sci       Date:  2021-11-14       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.